F-group (family)
2496.1.1.1 CRAL_TRIO
Ligands and drugs
532
Member domains
66
with ligand contacts (≤ 4 Å)
12.4% of members
61
with DrugDomain annotations
11.5% of members
43
with a DrugBank compound
8.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2496.1.1.1 belongs to X-group 2496 SpoIIaa-like, which binds 9.6 ligand superclasses per 20 proteins, broader than 89% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00163 | VIV | Vitamin E | 16 |
| DB03796 | PLM | Palmitic Acid | 3 |
| DB14094 | VTQ | Tocopherylquinone | 3 |
| DB18267 | HEM | Ferroheme | 3 |
| DB02080 | TRT | 1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene | 2 |
| DB04327 | PEE | Phosphatidylethanolamine | 2 |
| DB09459 | TLA | L-tartaric acid | 2 |
| DB11460 | SQL | Squalene | 2 |
| DB14001 | — | — | 2 |
| DB14002 | — | — | 2 |
| DB16857 | 11A | Undecanoic acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| VIV | (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL | 13 |
| CL | CHLORIDE ION | 9 |
| B7N | (1R)-2-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate | 7 |
| 3PT | (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dibutanoate | 4 |
| NImetal | NICKEL (II) ION | 4 |
| RET | RETINAL | 4 |
| 6PL | (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE | 3 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 3 |
| PBU | (2R)-3-{[(R)-HYDROXY{[(1R,2R,3S,4R,5R,6S)-2,3,6-TRIHYDROXY-4,5-BIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}PHOSPHORYL]OXY}PROPANE-1,2-DIYL DIBUTANOATE | 3 |
| PLM | PALMITIC ACID | 3 |
| POV | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate | 3 |
| SQL | (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene | 3 |
| VTQ | RRR-ALPHA-TOCOPHERYLQUINONE | 3 |
| 11A | UNDECANOIC ACID | 2 |
| 2TX | (3S)-2,2-dimethyl-3-[(3E,7E,11E,15E)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaen-1-yl]oxirane | 2 |
| 4PT | (2R)-3-{[(S)-{[(2S,3R,5S,6S)-2,6-DIHYDROXY-3,4,5-TRIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-(1-HYDROXYBUTOXY)PROPYL BUTYRATE | 2 |
| D21 | (2R)-1-(hexadecanoyloxy)-3-(phosphonooxy)propan-2-yl (9Z)-octadec-9-enoate | 2 |
| IUO | (4-chloranyl-3-nitro-phenyl)-[4-(2-fluorophenyl)piperazin-1-yl]methanone | 2 |
| KO0 | Himbacine | 2 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 2 |